Beijing, China, September 15, 2023 – MicroPort® Honghu Orthopedic Surgical Robot, developed by Suzhou MicroPort NaviBot (Suzhou) Co., Ltd., a subsidiary of Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot™), has officially obtained approval from the National Medical Products Administration (NMPA) for market release. This marks the first domestically produced hip and knee integrated orthopedic surgical robot featuring a self-developed mechanical arm to receive regulatory approval.
MicroPort® Honghu Orthopedic Surgical Robot
The MicroPort® Honghu Orthopedic Surgical Robot, designed for assisting in total knee arthroplasty (TKA) and total hip arthroplasty (THA), represents a significant advancement in both product functionality and surgical applications for the Honghu® orthopedic surgical robot.
About Medbot®
MedBot® commenced its development for laparoscopic surgical robots in 2014 (as an internal incubation project of MicroPort® group), and established a company in China in 2015 when its began to develop SkyWalker™ orthopedic surgical robot. We are committed to meeting the peak demand for robotic surgery. By integrating the cutting-edge research and robot ontology, control algorithms, electrical engineering, image-based navigation and precision imaging, we provide comprehensive intelligent surgical solutions to prolong and reshape the lives of patients, lead the maturity and development of robotic surgery, and shape the era of super intelligent surgery.
For more information, please visit: https://www.medbotsurgical.com/en/about